Another Israeli biotech is taken over

Buy-outs of Israeli medical innovators are regular events and recognise Israel’s success. This time, Florida-based Opko Health is buying Israel’s FineTech Pharmaceuticals – which develops “polymorphs” – different methods to deliver drugs without infringing patents.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *